Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,493
Closed -$256K 130
2026
Q1
$256K Hold
2,493
0.09% 110
2025
Q4
$312K Hold
2,493
0.11% 103
2025
Q3
$334K Hold
2,493
0.12% 108
2025
Q2
$339K Hold
2,493
0.13% 103
2025
Q1
$331K Sell
2,493
-58
-2% -$7.38K 0.13% 105
2024
Q4
$289K Buy
2,551
+58
+2% +$6.7K 0.11% 112
2024
Q3
$284K Hold
2,493
0.1% 113
2024
Q2
$259K Sell
2,493
-500
-17% -$53K 0.09% 117
2024
Q1
$340K Hold
2,993
0.13% 108
2023
Q4
$329K Hold
2,993
0.14% 107
2023
Q3
$290K Sell
2,993
-200
-6% -$21K 0.13% 111
2023
Q2
$348K Buy
+3,193
New +$340K 0.15% 101
2022
Q4
$296K Hold
2,700
0.15% 105
2022
Q3
$261K Hold
2,700
0.15% 108
2022
Q2
$293K Hold
2,700
0.14% 110
2022
Q1
$319K Hold
2,700
0.12% 104
2021
Q4
$380K Sell
2,700
-200
-7% -$25.6K 0.13% 104
2021
Q3
$343K Hold
2,900
0.13% 104
2021
Q2
$336K Sell
2,900
-7
-0.2% -$816 0.12% 101
2021
Q1
$348K Hold
2,907
0.13% 101
2020
Q4
$318K Hold
2,907
0.13% 104
2020
Q3
$316K Sell
2,907
-290
-9% -$29.4K 0.15% 95
2020
Q2
$292K Buy
+3,197
New +$289K 0.15% 94

Other funds holding ABT

Mathes Company's ABT Position: Q2 2026 in Review

Mathes Company sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,493 shares — an estimated $256K sold.

Mathes Company first reported a position in ABT in Q2 2020 and held it in 23 quarters. The position peaked at $380K in Q4 2021. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Mathes Company reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Mathes Company sold 2,493 Abbott shares in Q2 2026, an estimated $256K.
  • Mathes Company first reported a position in Abbott in Q2 2020 and held it in 23 quarters.
  • Mathes Company's Abbott position peaked at $380K in Q4 2021.
  • 2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.